Sign in

CIK 0001034842

  • Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943248524
Phone
+1 650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
  1. 4 Grant or award Director acquired 25,000 shares (grant or award)
  2. 4 Grant or award Director acquired 25,000 shares (grant or award)
  3. 4 Grant or award Director acquired 25,000 shares (grant or award)
  4. 4 Grant or award Director acquired 18,750 shares (grant or award)
  5. 4 Grant or award Director acquired 25,000 shares (grant or award)
  6. 4 Grant or award EVP &Chief Financial Officer acquired 50,000 shares (grant or award)
  7. 4 Grant or award EVP & CMO acquired 50,000 shares (grant or award)
  8. 4 Grant or award EVP, Chief Commercial Officer acquired 50,000 shares (grant or award)
  9. 4 Grant or award CEO, President acquired 200,000 shares (grant or award)
  10. 4 Grant or award EVP Corp. Affairs, G.C., Sect. acquired 50,000 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award Director acquired 6,250 shares (grant or award)
  18. 4 Grant or award Director acquired 25,000 shares (grant or award)
  19. 4 Grant or award Director acquired 25,000 shares (grant or award)
  20. 4 Grant or award Director acquired 25,000 shares (grant or award)

Page 7 of 34 · 664 filings